The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

OMNOVA Solutions Inc

NYSE: OMN
Last

(U.S.) $9.90

Today's change+0.08 +0.81%
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

OMNOVA Solutions Inc

NYSE: OMN
Last

(U.S.) $9.90

Today's change+0.08 +0.81%
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.

OMNOVA Solutions Inc up (U.S.)$0.08

OMNOVA Solutions Inc closed up Friday by (U.S.)$0.08 or 0.81% to (U.S.)$9.90. Over the last five days, shares have gained 0.51% and are currently 1.49% off of the 52-week high. Shares have outperformed the S&P 500 by 36.56% during the last year.

Key company metrics

  • Open(U.S.) $9.82
  • Previous close(U.S.) $9.82
  • High(U.S.) $9.91
  • Low(U.S.) $9.68
  • Bid / Ask-- / --
  • YTD % change+61.50%
  • Volume193,717
  • Average volume (10-day)557,838
  • Average volume (1-month)351,682
  • Average volume (3-month)236,000
  • 52-week range(U.S.) $4.37 to (U.S.) $10.05
  • Beta2.28
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.47×
  • Forward PEG0.57×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.28
Updated July 22 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1.57%

OMNOVA Solutions Inc has a net profit margin of -1.57%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMay 31, 201605/31/2016Feb 29, 201602/29/2016Nov 30, 201511/30/2015Aug 31, 201508/31/2015
Revenue202175200211
Total other revenue--------
Total revenue202175200211
Gross profit58444852
Total cost of revenue144131152159
Total operating expense192176220211
Selling / general / administrative33282830
Research & development--------
Depreciation / amortization7101010
Interest expense (income), net operating6687
Unusual expense (income)12214
Other operating expenses, total1-122
Operating income10-1-200
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax10-1-200
Income after tax7-1-190
Income tax, total30-1-1
Net income7-1-190
Total adjustments to net income--------
Net income before extra. items7-1-190
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7-1-190
Inc. avail. to common incl. extra. items7-1-190
Diluted net income7-1-190
Dilution adjustment--------
Diluted weighted average shares44444446
Diluted EPS excluding extraordinary itemsvalue per share0.16-0.03-0.430.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.180.00-0.130.06